Bactroban 2% nasal ointment 3g/ Bactroban 2% cream 15g - Beecham Group plc trading as GlaxoSmithKline UK (CLDA (15)A/06) - 24 August 2015
Beecham Group plc trading as GlaxoSmithKline UK is recalling specific batches of Bactroban 2% Nasal Ointment 3g and Bactroban 2% Cream 15g.
Product information
CLDA number
CLDA (15)A/06
MDR number
59-07/15
Company name
Beecham Group plc trading as GlaxoSmithKline UK
Product description
Bactroban 2% Nasal Ointment 3g - PL 00038/0347
Bactroban 2% Cream 15g - PL 00038/0372
Batch number/ expiry
| Bactroban 2% Nasal Ointment 3g | |
|---|---|
| Batch number | Expiry date |
| C683302 | 9 June 2017 |
| C694256 | 25 August 2017 |
| C699242 | 2 October 2017 |
| C700830 | 13 October 2017 |
| C722794 | 13 April 2018 |
| Bactroban 2% Cream 15g | |
|---|---|
| Batch number | Expiry date |
| C680732 | 16 November 2015 |
| C703976 | 2 May 2016 |
| C704955 | 12 May 2016 |
| C725156 | 10 October 2016 |
Brief description of problem
Wholesaler level recall due to potential risk of physical contamination with foreign materials associated with the manufacturing of the active substance, mupirocin calcium.
No complaints or adverse reactions relating to this issue have been received by the company to date.
Wholesalers are asked to return any affected stock to their supplier.
Company contact for medical information enquiries
GlaxoSmithKline UK Medical Information Department
Telephone: 0800 221441, option 2
Email: ukmedinfo@gsk.com
Advice for healthcare professionals and patients
This recall is to wholesalers only to prevent further distribution of the affected batches.
No complaints or adverse reactions relating to this issue have been received by the company to date.
Due to the very low level of risk, pharmacies may continue to dispense any stock and patients should continue using the products.
If you do experience any adverse reactions, please report them via the Yellow Card Scheme. You can also download the Yellow Card smartphone app from the iTunes App Store or Google Play for your IOS or Android device.
Contact GlaxoSmithKline UK Medical Information Department on 0800 221441, option 2, if you have any concerns with the product.